India erythromycin market is expected to grow at a substantial rate during the forecast period. Erythromycin is an antibiotic used to treat certain kind of bacterial infections. The India erythromycin market is driven by increasing number of drug developments. Moreover, rising prevalence of various infectious diseases in the country is forecasted to positively influence the market growth. Continuous research and developmental investments by pharmaceutical manufacturers is further expected to boost the growth of India erythromycin market through FY2026.

The India erythromycin market is segmented based on composition, application, source, form, distribution channel, route of administration, end user, company, and region. Based on application, the market can be segmented into respiratory tract infections, eye infections, ear infections, skin and soft tissue infection, gastro-intestinal infections and others. Among these, respiratory tract infections segment is expected to hold the major market share through FY2026 on account of high prevalence of respiratory tract infections amongst population. According to National Health Portal of India, acute respiratory infections accounted for around 69% of the total cases of communicable diseases in
India in 2019. Therefore, the efficient use of this drug for the treatment of respiratory infections, is further bolstering the market growth.

The major players operating in the India erythromycin market are Lupin Laboratories Ltd., Unicure India Private Ltd., Alkem Laboratories Ltd., Dr. Reddy’s Laboratories Ltd., Centurion Laboratories Private Ltd., Milan Laboratories India Pvt. Ltd., Systopic Laboratories Pvt. Ltd., Anuh Pharma Ltd., Envee Drugs Pvt. Ltd., Halycon Labs Private Limited., and others. Major companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments to expand their geographic reach and to increase their customer basis.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India erythromycin market from FY2016 to FY2019.
  • To estimate and forecast the market size of India erythromycin market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India erythromycin market based on composition, application, source, form, distribution channel, route of administration, end user, company, and regional distribution.
  • To identify dominant region or segment in the India erythromycin market.
  • To identify drivers and challenges for India erythromycin market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India erythromycin market.
  • To identify and analyze the profile of leading players operating in India erythromycin market.
  • To identify key sustainable strategies adopted by market players in India erythromycin market.


Click here to download the sample  

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India erythromycin market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.


Key Target Audience:

  • Erythromycin manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to erythromycin

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India erythromycin market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Erythromycin Market, By Composition:
    • Erythromycin estolate
    • Erythromycin stearate
  • India Erythromycin Market, By Application:
    • Respiratory Tract Infections
    • Eye Infections
    • Ear Infections
    • Skin and Soft Tissue Infection
    • Gastro-intestinal Infections
    • Others
  • India Erythromycin Market, By Source:
    • In-house
    • Contract Manufacturing Organizations
  • India Erythromycin Market, By Form:
    • Gel
    • Tablet
    • Capsule
    • Injection
    • Ointment
    • Ear and Eye Drops
  • India Erythromycin Market, By Distribution Channel:
    • Online
    • Offline
  • India Erythromycin Market, By Route of Administration:
    • Oral
    • Topical
    • Intravenous
    • Otic
    • Ophthalmic
  • India Erythromycin Market, By End User:
    • Adult
    • Paediatric
  • India Erythromycin Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India erythromycin market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India erythromycin market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Erythromycin Market

4.    Executive Summary

5.    Manufacturing Erythromycin

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Erythromycin

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Erythromycin Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Composition (Erythromycin Estolate V/S Erythromycin Stearate)

7.2.2.     By Application (Respiratory Tract Infections, Eye Infections, Ear Infections, Skin and Soft Tissue Infection, Gastro-intestinal Infections and Others)

7.2.3.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.4.     By Form (Gel, Tablet, Capsule, Injection, Ointment, Ear and Eye Drops)

7.2.5.     By Distribution Channel (Online v/s Offline)

7.2.6.     By Route of Administration (Oral, Topical, Intravenous, Otic and Ophthalmic)

7.2.7.     By End User (Adult v/s Paediatric)

7.2.8.     By Region (North, East, South, West)

7.2.9.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Lupin Laboratories Ltd.

14.1.1.1.      Company Brief

14.1.1.2.      Production Plants & Capacity (If Available)

14.1.1.3.      Financials (If Available)

14.1.1.4.      Captive Consumption Vs Merchant Sale

14.1.1.5.      Current & Future Plans

14.1.2.  Unicure India Private Ltd.

14.1.3.  Alkem Laboratories Ltd.

14.1.4.  Dr. Reddy’s Laboratories Ltd.

14.1.5.  Centurion Laboratories Private Ltd.

14.1.6.  Milan Laboratories India Pvt. Ltd.

14.1.7.  Systopic Laboratories Pvt. Ltd.

14.1.8.  Anuh Pharma Ltd.

14.1.9.  Envee Drugs Pvt. Ltd.

14.1.10.                Halycon Labs Private Limited

15.  Strategic Recommendations

16. About Us & Disclaimer